These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 36125593)

  • 1. An Old Bridge to the Newer Biologics: Cyclosporine for Rescue Therapy in Acute Severe Ulcerative Colitis.
    Ashat D; Jain A; Weaver KN; Long MD; Herfarth HH; Barnes EL
    Dig Dis Sci; 2022 Dec; 67(12):5439-5443. PubMed ID: 36125593
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of Acute Severe Colitis in Children With Ulcerative Colitis in the Biologics Era.
    Romano C; Syed S; Valenti S; Kugathasan S
    Pediatrics; 2016 May; 137(5):. PubMed ID: 27244779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rescue Therapies for Steroid-refractory Acute Severe Ulcerative Colitis: A Review.
    Gisbert JP; García MJ; Chaparro M
    J Crohns Colitis; 2023 Jun; 17(6):972-994. PubMed ID: 36652279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infliximab versus cyclosporine for severe ulcerative colitis refractory to steroids: A protocol for systematic review and meta-analysis.
    Wu D; Yang Z; Zhao C; Yao L
    Medicine (Baltimore); 2018 Oct; 97(41):e12657. PubMed ID: 30313056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Induction Therapy With Calcineurin Inhibitors in Combination With Ustekinumab for Acute Severe Ulcerative Colitis.
    Veyrard P; Pellet G; Laharie D; Nachury M; Juillerat P; Roblin X
    Clin Gastroenterol Hepatol; 2023 May; 21(5):1354-1355.e2. PubMed ID: 35307594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrating efficacy and safety of vedolizumab compared with other advanced therapies to assess net clinical benefit of ulcerative colitis treatments: a network meta-analysis.
    Jairath V; Chan K; Lasch K; Keeping S; Agboton C; Blake A; Patel H
    Expert Rev Gastroenterol Hepatol; 2021 Jun; 15(6):711-722. PubMed ID: 33599181
    [No Abstract]   [Full Text] [Related]  

  • 7. [Biologics treatment for ulcerative colitis].
    Nagahori M; Fujii T; Saito E; Ohtsuka K; Watanabe M
    Nihon Shokakibyo Gakkai Zasshi; 2013 Nov; 110(11):1909-15. PubMed ID: 24189818
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical outcomes with ustekinumab as rescue treatment in therapy-refractory or therapy-intolerant ulcerative colitis.
    Ochsenkühn T; Tillack C; Szokodi D; Janelidze S; Schnitzler F
    United European Gastroenterol J; 2020 Feb; 8(1):91-98. PubMed ID: 32213052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of the Most Cost-effective Position of Vedolizumab Among the Available Biologic Drugs for the Treatment of Ulcerative Colitis.
    Scott FI; Luo M; Shah Y; Lasch K; Vajravelu RK; Mamtani R; Fennimore B; Gerich ME; Lewis JD
    J Crohns Colitis; 2020 Jun; 14(5):575-587. PubMed ID: 31901085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclosporine for severe steroid-refractory ulcerative colitis: commenting the comment.
    Actis GC; Pellicano R
    Minerva Gastroenterol Dietol; 2018 Sep; 64(3):190-192. PubMed ID: 29327818
    [No Abstract]   [Full Text] [Related]  

  • 11. Biologic Therapy for Ulcerative Colitis.
    Bhattacharya A; Osterman MT
    Gastroenterol Clin North Am; 2020 Dec; 49(4):717-729. PubMed ID: 33121691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Market Access Analysis of Biologics and Small-Molecule Inhibitors for Inflammatory Bowel Disease Among US Health Insurance Policies.
    Dulai PS; Osterman MT; Lasch K; Cao C; Riaz F; Sandborn WJ
    Dig Dis Sci; 2019 Sep; 64(9):2478-2488. PubMed ID: 30923985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic Review and Meta-Analysis: Infliximab or Cyclosporine as Rescue Therapy in Patients With Severe Ulcerative Colitis Refractory to Steroids.
    Narula N; Marshall JK; Colombel JF; Leontiadis GI; Williams JG; Muqtadir Z; Reinisch W
    Am J Gastroenterol; 2016 Apr; 111(4):477-91. PubMed ID: 26856754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of outcomes of cyclosporine A and infliximab for steroid-refractory acute severe ulcerative colitis.
    Dai C; Jiang M; Huang YH
    J Gastroenterol Hepatol; 2021 Jul; 36(7):2024-2025. PubMed ID: 33880817
    [No Abstract]   [Full Text] [Related]  

  • 15. Ciclosporin or Infliximab as Rescue Therapy in Acute Glucorticosteroid-Refractory Ulcerative Colitis: Systematic Review and Network Meta-Analysis.
    Barberio B; Black CJ; Savarino EV; Ford AC
    J Crohns Colitis; 2021 May; 15(5):733-741. PubMed ID: 33175102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ability of different rescue therapies to save the bowel in acute, severe, steroid-refractory ulcerative colitis.
    Farkas K; Molnár T; Szepes Z
    Expert Rev Gastroenterol Hepatol; 2014 Aug; 8(6):695-702. PubMed ID: 24738535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological therapy for ulcerative colitis: an update.
    Seo GS; Chae SC
    World J Gastroenterol; 2014 Oct; 20(37):13234-8. PubMed ID: 25309060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accelerated ustekinumab dosing as rescue therapy in acute severe ulcerative colitis.
    Affendi NANM; Ooi CJ; Hilmi IN
    J Gastrointestin Liver Dis; 2022 Dec; 31(4):478-479. PubMed ID: 36535053
    [No Abstract]   [Full Text] [Related]  

  • 19. Two Strikes but Not Out: Deep Remission of Ulcerative Colitis with Ustekinumab After Primary Non-response to Infliximab and Vedolizumab.
    Dalal RS; Ananthakrishnan AN; Hamilton MJ; Winter RW
    Dig Dis Sci; 2021 Mar; 66(3):733-737. PubMed ID: 33569666
    [No Abstract]   [Full Text] [Related]  

  • 20. Colectomy rates in patients with ulcerative colitis following treatment with infliximab or ciclosporin: a systematic literature review.
    Thorne K; Alrubaiy L; Akbari A; Samuel DG; Morrison-Rees S; Roberts SE
    Eur J Gastroenterol Hepatol; 2016 Apr; 28(4):369-82. PubMed ID: 26825217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.